thalidomide

Also known as K-17, 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline, N-(2,6-dioxo-3-piperidyl)phthalimide, (±)-thalidomide, 3-Phthalimidoglutarimide, N-Phthalyl-glutaminsaeure-imid, Talidomida, Thalidomidum

Thalidomide, sold under the brand names Contergan, Distaval and Thalomid among others, is an oral administered medication used to treat a number of cancers (e.g., multiple myeloma), graft-versus-host disease, and many skin disorders (e.g., complications of leprosy such as skin lesions). Thalidomide has been used to treat conditions associated with HIV: aphthous ulcers, HIV-associated wasting syndrome, diarrhea, and Kaposi's sarcoma, but increases in HIV viral load have been reported.

AI overview

Thalidomide is a medication taken by mouth that is used today to treat various cancers, graft-versus-host disease, skin conditions, and certain HIV-related problems. It matters because it is an effective treatment option for several serious medical conditions, though it has been associated with some complications in certain uses, such as increases in HIV viral load in some patients.

AI-generated from the Wikipedia summary — may contain errors.

In the Vinony graph

Vinony's link graph records 1,091 inbound references to thalidomide, and connects out to United States Food and Drug Administration, teratology and angiogenesis inhibitor.

It is catalogued under topics including 20th-century health disasters, Antileprotic drugs and Causes of amputation.

Vinony links it to 52 Wikipedia language editions.

Key facts

Drug.Watchedfields: changed
Drug.Verifiedfields: changed
Drug.verifiedrevid: 420478187
Drug.image: Thalidomide enantiomers.svg
Drug.image_class: skin-invert-image
Drug.width: 200
Drug.chirality: Racemic mixture
Drug.tradename: Contergan, Thalomid, others
Drug.MedlinePlus: a699032
Drug.licence_EU: yes
Drug.DailyMedID: Thalidomide
Drug.licence_US: Thalidomide
Drug.pregnancy_AU: X
Drug.routes_of_administration: By mouth
Drug.ATC_prefix: L04
Drug.ATC_suffix: AX02
Drug.legal_AU: S4
Drug.legal_BR: C3

via Wikipedia infobox

Chemical data

Formula: C13H10N2O4
Molecular weight: 258.23 g/mol
IUPAC name: 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
SMILES: C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
InChIKey: UEJJHQNACJXSKW-UHFFFAOYSA-N
XLogP: 0.3
Polar surface area: 83.6 Å²
H-bond donors: 1
H-bond acceptors: 4
Formal charge: 0

via PubChem

Drug data · ChEMBL

Withdrawn

Max clinical phase: Approved
Molecule type: Small molecule
First approval: 1956
Admin. routes: oral
Indications: immune system disease, Crohn's disease, systemic scleroderma, sarcoma

via ChEMBL · EBI